Remote Patient Monitoring Segmentation
Indication (Oncology, Diabetes, Hypertension, COPD, Congestive Heart Failure)
The oncology segment is projected to witness noteworthy growth over the forecast period. The growth of the segment can be credited to rising cases of cancer globally, increasing awareness regarding healthcare owing to advancements in medical treatment, and increasing access to insurance. For instance, nearly 400 new cases of cancer per 100,000 individuals are diagnosed every year.
Our in-depth analysis of the global market includes the following segments:
|
By Monitoring Type |
|
|
By Type |
|
|
By Component |
|
|
By Indication |
|
|
By End-User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Remote Patient Monitoring Market in 2025 is evaluated at USD 9.86 billion.
The global market size was worth more than USD 8.53 billion in 2024 and is poised to witness a CAGR of over 19.5%, crossing USD 86.44 billion revenue by 2037.
North America leads, backed by major key players and growing chronic disease prevalence.
The major players in the market include F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott Laboratories, Bio Telemetry, Inc., Boston Scientific Corporation, Omron Corporation, Masimo Corporation, Edward Lifesciences Corporation, Nihon Kohden Corporation, Medtronic plc.
